BLEPHAMIDE: SULFACETAMIDE SODIUM,PHENYLEPHRI.
SULFACETAMIDE SODIUM,PHENYLEPHRI. Key specifications include administration: OPHTHALMIC, special_features: W/SUSPENDING AND THICKENING AGENTS; W/BUFFERS AND PRESERVATIVES, features_provided: STERILE, primary_container_type: TUBE WITH OPHTHALMIC TIP, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-903-9220, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | OPHTHALMIC |
| special_features | W/SUSPENDING AND THICKENING AGENTS; W/BUFFERS AND PRESERVATIVES |
| features_provided | STERILE |
| primary_container_type | TUBE WITH OPHTHALMIC TIP |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 3.500 GRAMS G |
| active_medicament_medicinal_strength | 0.200 PERCENTAGE, W/V PREDNISOLONE ACETATE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SULFACETAMIDE SODIUM ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | SULFACETAMIDE SODIUM & PREDNISOLONE ACETATE OPHTHALMIC OINT 35GM |
| NSN | 6505-00-903-9220 |
| ADMINISTRATION | OPHTHALMIC |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | W/SUSPENDING AND THICKENING AGENTS; W/BUFFERS AND PRESERVATIVES |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.120 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.200 PERCENTAGE, W/V PREDNISOLONE ACETATE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SULFACETAMIDE SODIUM ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.